Using bacteria to fight cancer

Israel’s NeoTX uses Selective T cell Redirection (STR) technology to enlist a powerful immune response against tumors. Mutated bacteria are fused with monoclonal antibodies which target the tumor’s 5T4 antigen, alerting T-cells to kill the tumor.  NeoTX has just raised $45 million of funds.,7340,L-3794957,00.html

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *